ImmunityBio OverviewImmunityBio EBIT
EBIT (Earnings Before Interest and Taxes) analysis for IBRX.
Quarterly EBIT
-$69.79M
↓ 8.32% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$207.84M
↑ 23.03% YoY
Trailing 12 months ending Mar 31, 2026
ImmunityBio OverviewEBIT (Earnings Before Interest and Taxes) analysis for IBRX.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026